Some patients may experience mild nausea, digestive changes, or a decreased appetite, which typically improve over time
A doctor may choose one brand over another based on: your starting dose and escalation plan whether you have type 2 diabetes, obesity, or both whether you need a vial, cartridge, reusable pen, or disposable pen your tolerance to nausea, vomiting, and appetite suppression your long-term affordability and adherence This is especially important because semaglutide treatment usually works best when used under proper medical supervision, along with diet correction, protein planning, and physical activity
And they blast Christmas music
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-1)